Login

$ONMD SEC Filings

Filed On Filing
16 Nov 2026 424B3
16 Nov 2026 10-Q
13 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 8-K: Results of Operations and Financial Condition

OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap

06 Nov 2026 8-K: Results of Operations and Financial Condition

MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-Wor...

14 Oct 2026 8-K: Other Events

As previously disclosed, on April 14, 2026, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it...

13 Oct 2026 Form 4: Kosasa Thomas, Director

Bought 129,758 shares ($750K)

13 Oct 2026 Form 4: Yu Jeffrey, Director

Bought 45,126 shares ($250K)

09 Oct 2026 Form 4: Golden Robert Lawrence, Director

Received 10,000 shares as a grant or award · Received 35,000 shares as a grant or award · Sold 2,500 shares ($16.5K) · 2 more

09 Oct 2026 Form 4: Green Aaron, Director

Received 65,000 shares as a grant or award · Sold 5,000 shares ($37K) · Sold 1,667 shares ($10.8K)

30 Sep 2026 424B3
30 Sep 2026 424B3
29 Sep 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year

MINNEAPOLIS, Minn.– September 25, 2026– OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announ...

23 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

1. Purpose. The purpose of the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan (the “Plan”) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a me...

14 Sep 2026 Form 4: Yu Jeffrey, Director

Bought 142,857 shares ($90K)

20 Aug 2026 424B3
20 Aug 2026 424B3
19 Aug 2026 Proxy statement: annual meeting on September 18, 2026
14 Aug 2026 10-Q
07 Aug 2026 Form 4: Kosasa Thomas, Director

Bought 1,449,275 shares ($1M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support